Literature DB >> 18685856

[Dermatological symptoms in rheumatology].

E Aberer1.   

Abstract

The connective tissue of the skin, joints and musculoskeletal system is often involved concomittantly in rheumatic diseases. Specific skin lesions can be the hallmark of certain collagen vascular diseases, but unspecific dermatoses like purpura, neutrophilic dermatoses or ulcers are also common. Recent investigations suggest that the different histopathologic reaction patterns are derived from cytokine- and chemokine-mediated processes. Thus neutrophilic dermatoses are observed in rheumatic, hematologic and gastric diseases, or in patients without apparent disease. The mediators causing interphase dermatitis seen in LE, dermatomyositis, lichen planus or lichen sclerosus have recently be described. The knowledge gained from these findings opens an avenue for the development of new therapeutic agents.

Entities:  

Mesh:

Year:  2008        PMID: 18685856     DOI: 10.1007/s00393-008-0341-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  68 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Diagnosis of nail psoriasis: importance of biopsy and histopathology.

Authors:  C Grover; B S N Reddy; K Uma Chaturvedi
Journal:  Br J Dermatol       Date:  2005-12       Impact factor: 9.302

3.  Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases.

Authors:  D Blockmans; G Beyens; R Verhaeghe
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

4.  ICF core sets: how to specify impairment and function in systemic lupus erythematosus.

Authors:  M Aringer; T A Stamm; D S Pisetsky; C H Yarboro; A Cieza; J S Smolen; G Stucki
Journal:  Lupus       Date:  2006       Impact factor: 2.911

5.  Distinctive cutaneous subsets in the spectrum of lupus erythematosus.

Authors:  J N Gilliam; R D Sontheimer
Journal:  J Am Acad Dermatol       Date:  1981-04       Impact factor: 11.527

Review 6.  DRESS syndrome in a patient on sulfasalazine for rheumatoid arthritis.

Authors:  Fabrice Michel; Jean-Christophe Navellou; Denis Ferraud; Eric Toussirot; Daniel Wendling
Journal:  Joint Bone Spine       Date:  2005-01       Impact factor: 4.929

Review 7.  Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches.

Authors:  Joerg Wenzel; Thomas Tüting
Journal:  Exp Dermatol       Date:  2007-05       Impact factor: 3.960

Review 8.  Rediscovering thalidomide: a review of its mechanism of action, side effects, and potential uses.

Authors:  S Tseng; G Pak; K Washenik; M K Pomeranz; J L Shupack
Journal:  J Am Acad Dermatol       Date:  1996-12       Impact factor: 11.527

Review 9.  Systemic scleroderma. Clinical and pathophysiologic aspects.

Authors:  T Krieg; M Meurer
Journal:  J Am Acad Dermatol       Date:  1988-03       Impact factor: 11.527

10.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.